‘Stealth’ Prostate Tumors

SIMPLE SUMMARY: Efforts are ongoing to improve the diagnosis of prostate cancer. Novel blood and tissue-based biomarkers, advanced imaging modalities and image-guided biopsy techniques have further improved cancer detection rates. However, approximately 30–40% of cancers are still missed. Analysis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagaskar, Vinayak G., Zaytoun, Osama, Bhardwaj, Swati, Tewari, Ash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341057/
https://www.ncbi.nlm.nih.gov/pubmed/37444597
http://dx.doi.org/10.3390/cancers15133487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341057/
https://www.ncbi.nlm.nih.gov/pubmed/37444597
http://dx.doi.org/10.3390/cancers15133487

Ejemplares similares